SanBio Co Stock

SanBio Co EPS

The Earnings per Share (EPS) of SanBio Co (4592.T) as of Aug 7, 2026 is -41.86 JPY. In the previous year, Earnings per Share (EPS) was -40.48 JPY — a change of 3.41% (lower).

EPS

-41.86JPY

YoY

3.41%

Last updated:

Earnings per Share (EPS) of SanBio Co is 2026 -41.86 JPY. Earnings per Share (EPS) of SanBio Co was 2025 -40.48 JPY. It decreases by 3.41% lower compared to the previous year.
Access this data via the Eulerpool API

SanBio Co Stock analysis

What does SanBio Co do? SanBio Co Ltd is a leading bio-pharmaceutical company focused on the development of products for the treatment of serious neurological diseases. The company was founded in Japan in 2000 and has since become a multinational company with offices in the USA and Europe. Answer: SanBio Co Ltd is a bio-pharmaceutical company that specializes in developing products for the treatment of serious neurological diseases. It was founded in Japan in 2000 and has expanded to become a multinational company with offices in the USA and Europe. SanBio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SanBio Co stock

Earnings per Share (EPS) of SanBio Co is -41.86 JPY in 2026.

Earnings per Share (EPS) of SanBio Co changed from -40.48 JPY to -41.86 JPY, representing a 3.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) SanBio Co since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

Income Statement — SanBio Co

All Key Metrics — SanBio Co